Impact of ‘dry days’ on quality of life in patients with ‘wet’ overactive bladder: results of a pooled analysis of three phase III studies with darifenacin

Abstract Category

Quality of Life (QoL)

Links
	Abstract 56
	Quality of Life & Epidemiology Scientific Podium Poster Session 6
	Thursday 1st October 2009
	15:15 - 15:20
	Hall C
	1. University of Pennsylvania, 2. Procter & Gamble Pharmaceuticals, 3. Novartis Pharmaceuticals Corporation, 4. CTI Clinical Trial & Consulting Services
Presenter
D D Newman
Abstract PDF Edit Abstract Abstract Centre